<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/oryzon-ema-cta-vafidemstat-hope-2-phelan-mcdermid-syndrome</loc>
    <lastmod>2026-09-28T13:38:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28T00:00:00+05:30</news:publication_date>
      <news:title>Oryzon Gains Ema Cta For Vafidemstat Phase Ii Pms Study</news:title>
      <news:keywords>Oryzon</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.oryzon.com/sites/default/files/inline-images/ndp23-2026-en.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/inventiva-nativ3-phase-3-topline-results-lanifibranor-mash-2026</loc>
    <lastmod>2026-09-28T13:39:19+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28T00:00:00+05:30</news:publication_date>
      <news:title>Inventiva Awaits Phase 3 Nativ3 Data For Lanifibranor</news:title>
      <news:keywords>Inventiva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c267b587-2897-4246-b89d-af11b0ff7eb9/0c3107d1-9b0b-4111-a0f1-9d6a29d156d3.png</image:loc>
    </image:image>
  </url>
</urlset>